Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 804, Issue 2, 2004, Pages 431-434

  Velpandian, Thirumurthy ^a   Mathur, Rajani ^b   Agarwal, Nitin K ^a   Arora, Brijesh ^c   Kumar, Lalit ^c   Gupta, Suresh K ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Imatinib

Indexed keywords

ACETONITRILE; BIOASSAY; LIQUID CHROMATOGRAPHY; PHARMACOKINETICS;

PHOTODIODE ARRAY;

BIOMEDICAL ENGINEERING;

ACETONITRILE; DRUG METABOLITE; IMATINIB; METHANOL; PLASMA PROTEIN; POTASSIUM DIHYDROGEN PHOSPHATE;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; CHRONIC MYELOID LEUKEMIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; ELUTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STANDARD; SUPERNATANT; ULTRAVIOLET RADIATION;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; NEOPLASMS; PIPERAZINES; PYRIMIDINES; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 1842787859     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.01.032     Document Type: Article

References (16)

1. Druker B.J., Tamura S., Buchdunger E.et al. Nat. Med. 2:1996;561.
2. Deininger M.W.N., Goldman J.M., Lydon N.et al. Blood. 90:1997;3691.
3. Gambacorti-Passerini C., Coutre le.P., Mologni L.et al. Blood Cells Mol. Dis. 23:1997;380.
4. Carroll M., Ohno-Jones S., Tamura S.et al. Blood. 90:1997;4947.
5. le Coutre P., Mologni L., Cleris L.et al. J. Natl. Cancer Inst. 91:1999;163.
6. Buchdunger E., Zimmermann J., Mett H.et al. Cancer Res. 56:1996;100.
7. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., Sawyers C.L. N. Engl. J. Med. 344:2001;1031.
8. O'Brien S.G., Guilhot F., Larson R.A.et al. N. Engl. J. Med. 348:2003;994.
9. Novartis, Glivec, Summary of Product Characteristics, 2001.
10. Cohen M.H., Williams G., Johnson J.R.et al. Clin. Cancer Res. 8:2002;935.
11. OECD Guideline for testing of chemicals - partition coefficient (n-octanol/water): high performance liquid chromatography (HPLC), Method Draft Guideline 117, November 2000.
12. Cohen M.H., Dagher R., Griebel D.J., Ibrahim A., Martin A., Scher N.S., Sokol G.H., Williams G.A., Pazdur R. Oncologist. 7:2002;393.
13. Kolars J.C., Schmiedlin-Ren P., Schuetz J.D., Fang C., Watkins P.B. J. Clin. Invest. 90:1992;1871.
14. Bakhtiar R., Khemani L., Hayes M., Bedman T., Tse F. J. Pharm. Biomed. Anal. 28:2002;1183.
15. Bakhtiar R., Lohne J., Ramos L., Khemani L., Hayes M., Tse F. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 768:2002;325.
16. Validation of analytical procedures: methodology Q2B, Recommended for adoptation at Step ICH process on 6 November 1996 by ICH Sterring Committee.